Makoto Takeuchi - Corporate Executive @ Astellas Pharma

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Neusignal Therapeutics	Fast Track Initiative, Inc.	—	Series A - Neusignal Therapeutics	obfuscated obfuscation

Number of Current Jobs

has

current jobs as

Executive Vice President

and

Corporate Executive

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

is the

Corporate Auditor

Organization Name	Title At Company	Start Date	End Date
Braizon Therapeutics	Board Member	—	—

Hub Name	CB Rank (Hub)
Tokyo Public Companies With More Than 50 Employees	15,645
Japan Companies With More Than 500 Employees	6,220
Japan Public Companies With More Than 100 Employees	16,391
Japan Companies With More Than $50M in Revenue	9,192
City of Tokyo Companies With More Than $1B in Revenue	102,439
Japan Medical Companies	34,706
City of Tokyo Public Companies With More Than $500 in Revenue	11,473
City of Tokyo Companies With More Than 100 Employees	7,877
Companies that Went Public in 1949	58,362
Asia Medical Public Companies	47,181

There is no recent news or activity for this profile.